首页|Acquired resistance to PD-L1 inhibition is associated with an enhanced type I IFN-stimulated secretory program in tumor cells

Acquired resistance to PD-L1 inhibition is associated with an enhanced type I IFN-stimulated secretory program in tumor cells

Hill James W. Shi Yuhao McKenery Amber Benzekry Sebastien Ebos John M.L. Dommer Adam Dolan Melissa Puzanov Igor Mastri Michalis Abrams Scott Long Mark

DOI：10.1101/2021.07.01.450417

来源：

bioRxiv

Acquired resistance to PD-L1 inhibition is associated with an enhanced type I IFN-stimulated secretory program in tumor cells

Hill James W. Shi Yuhao McKenery Amber Benzekry Sebastien Ebos John M.L. Dommer Adam Dolan Melissa Puzanov Igor Mastri Michalis Abrams Scott Long Mark

作者信息

引用本文复制引用

Hill James W.,Shi Yuhao,McKenery Amber,Benzekry Sebastien,Ebos John M.L.,Dommer Adam,Dolan Melissa,Puzanov Igor,Mastri Michalis,Abrams Scott,Long Mark.Acquired resistance to PD-L1 inhibition is associated with an enhanced type I IFN-stimulated secretory program in tumor cells[EB/OL].(2025-03-28)[2025-12-13].https://www.biorxiv.org/content/10.1101/2021.07.01.450417.

学科分类

肿瘤学/基础医学/生物科学研究方法、生物科学研究技术

首发时间： 2025-03-28

下载量：0

点击量：2

段落导航

Acquired resistance to PD-L1 inhibition is associated with an enhanced type I IFN-stimulated secretory program in tumor cells

Acquired resistance to PD-L1 inhibition is associated with an enhanced type I IFN-stimulated secretory program in tumor cells

引用本文复制引用

学科分类

评论